[go: up one dir, main page]

WO2007026379A3 - Novel crystalline forms of risedronate monosodium - Google Patents

Novel crystalline forms of risedronate monosodium Download PDF

Info

Publication number
WO2007026379A3
WO2007026379A3 PCT/IN2006/000315 IN2006000315W WO2007026379A3 WO 2007026379 A3 WO2007026379 A3 WO 2007026379A3 IN 2006000315 W IN2006000315 W IN 2006000315W WO 2007026379 A3 WO2007026379 A3 WO 2007026379A3
Authority
WO
WIPO (PCT)
Prior art keywords
crystalline forms
novel crystalline
risedronate monosodium
risedronate
monosodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2006/000315
Other languages
French (fr)
Other versions
WO2007026379A2 (en
Inventor
Reddy Muddasani Pulla
Rani Vattikuti Usha
Chowdary Nannapaneni Venkaiah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natco Pharma Ltd
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Publication of WO2007026379A2 publication Critical patent/WO2007026379A2/en
Publication of WO2007026379A3 publication Critical patent/WO2007026379A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Present invention is related to three novel crystalline forms of risedronate monosodium of Formula (I) and processes for the preparation of same. These forms are stable and suitable for pharmaceutical formulations.
PCT/IN2006/000315 2005-08-30 2006-08-30 Novel crystalline forms of risedronate monosodium Ceased WO2007026379A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1209CH2005 2005-08-30
IN1209/CHE/2005 2005-08-30

Publications (2)

Publication Number Publication Date
WO2007026379A2 WO2007026379A2 (en) 2007-03-08
WO2007026379A3 true WO2007026379A3 (en) 2007-07-12

Family

ID=37709614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000315 Ceased WO2007026379A2 (en) 2005-08-30 2006-08-30 Novel crystalline forms of risedronate monosodium

Country Status (1)

Country Link
WO (1) WO2007026379A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5052816B2 (en) * 2006-04-26 2012-10-17 株式会社パーマケム・アジア Method for producing 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium salt 2.5 hydrate A-type crystal
JP2009536639A (en) 2006-05-11 2009-10-15 アイエヌディー−スイフト ラボラトリーズ リミテッド Process for preparing pure risedronic acid or salt

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186405A2 (en) * 1984-12-21 1986-07-02 The Procter & Gamble Company Pharmaceutical compositions containing geminal diphosphonates
WO2003086355A1 (en) * 2002-04-11 2003-10-23 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186405A2 (en) * 1984-12-21 1986-07-02 The Procter & Gamble Company Pharmaceutical compositions containing geminal diphosphonates
WO2003086355A1 (en) * 2002-04-11 2003-10-23 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium

Also Published As

Publication number Publication date
WO2007026379A2 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
WO2008005565A3 (en) Antiviral phosphinate compounds
WO2009080638A3 (en) Sulfamides as zap-70 inhibitors
WO2006020276A3 (en) Antiviral compounds
NZ553405A (en) Nucleoside phosphonate conjugates as anti-HIV agents
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
WO2008013838A3 (en) Pyridizinone derivatives
WO2009005677A3 (en) Antiviral compounds
WO2009005676A3 (en) Antiviral compounds
WO2007009109A3 (en) Antiviral compounds
WO2009005690A3 (en) Antiviral compounds
WO2004096234A3 (en) Kinase inhibitor phosphonate conjugates
WO2009111653A3 (en) Antiviral therapeutic agents
WO2004096285A3 (en) Anti-infective phosphonate conjugates
WO2006053255A3 (en) Novel betulin derivatives, preparation thereof and use thereof
WO2005002626A3 (en) Therapeutic phosphonate compounds
WO2006021213A3 (en) Vasopressin v1a antagonists
MX2007005221A (en) Ascomycin crystalline forms and preparation thereof.
WO2009082152A3 (en) Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
WO2011006935A3 (en) Tetrazole derivatives
WO2009105969A8 (en) Epothilone analogues, their pharmaceutical compositions, their use and their preparations
WO2007014352A3 (en) Antiviral phosphonate conjugates for inhibition of hiv
WO2009040314A3 (en) Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2
WO2008001201A3 (en) Pharmaceutical compositions of clopidogrel
TW200716568A (en) 1H-quinazoline-2,4-diones
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06796194

Country of ref document: EP

Kind code of ref document: A2